Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 3;24(1):556.
doi: 10.1186/s12885-024-12317-3.

Advances in personalized radiotherapy

Venkata Sk Manem  1   2 , Farzad Taghizadeh-Hesary  3   4
Affiliations
Editorial

Advances in personalized radiotherapy

Venkata Sk Manem et al. BMC Cancer. .

Abstract

Radiotherapy is a mainstay of cancer treatment. The clinical response to radiotherapy is heterogeneous, from a complete response to early progression. Recent studies have explored the importance of patient characteristics in response to radiotherapy. In this editorial, we invite contributions for a BMC Cancer collection of articles titled 'Advances in personalized radiotherapy' towards the improvement of treatment response.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Trapani D, Franzoi MA, Burstein HJ, Carey LA, Delaloge S, Harbeck N, et al. Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification. Ann Oncol. 2022;33(7):702–12. doi: 10.1016/j.annonc.2022.03.273. - DOI - PubMed
    1. Behnam B, Taghizadeh-Hesary F. Mitochondrial metabolism: a New Dimension of Personalized Oncology. Cancers. 2023;15(16):4058. doi: 10.3390/cancers15164058. - DOI - PMC - PubMed
    1. Whelan TJ, Smith S, Nielsen TO, Parpia S, Fyles AW, Bane A, et al. LUMINA: a prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC) J Clin Oncol. 2022;40(17suppl):LBA501–LBA. doi: 10.1200/JCO.2022.40.17_suppl.LBA501. - DOI
    1. Gogineni K, Kalinsky K. Individualizing adjuvant therapy in women with hormone Receptor–Positive, human epidermal growth factor receptor 2–Negative node-positive breast Cancer. JCO Oncol Pract. 2022;18(4):247–51. doi: 10.1200/OP.21.00780. - DOI - PubMed
    1. Heidinger M, Maggi N, Dutilh G, Mueller M, Eller RS, Loesch JM, et al. Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital. World J Surg Oncol. 2023;21(1):176. doi: 10.1186/s12957-023-03062-1. - DOI - PMC - PubMed

Publication types